Skip to content

📢 Latest Update

FDA shifts 60-year default: One pivotal clinical trial is now the default for drug approval – replacing the two-trial requirement

Read the full story →

Home
Company
Pipeline
Products
Technology
News
Careers
Contact
Team
IP
Contact us
Contact us

Day: March 16, 2026

GNQ Insilico Inc. to go Public Through Business Combination With IB Acquisition Corp. (NASDAQ: IBAC)

IB Acquisition Corp. Mon, March 16, 2026 at 1:45 PM EDT 12 min read   BOCA RATON, FL AND TORONTO, ONTARIO, March 16, 2026 (GLOBE NEWSWIRE) — GNQ Insilico Inc. (“GNQ” or the “Company”), a corporation formed under the federal laws of Canada, and IB Acquisition Corp. (Nasdaq: IBAC) (“IBAC”), a Nevada special purpose acquisition […]

Quick Links

home
company
pipeline
products
technology
News
Careers
Contact
IP

CONTACT US

  • GNQ Insilico Inc., 6200 Stoneridge Mall Rd, Ste 300 Pleasanton, California 94588
  • info@gnq.ai
  • LinkedIn

© 2026 GNQ INSILICO INC. ALL RIGHTS RESERVED.

PRIVACY POLICY - DISCLAIMER